Overview
Chemicals

Yuki Gosei Kogyo Co.,Ltd.

Yuki Gosei Kogyo is a fine chemicals manufacturer engaged in the production and sale of amino acids and vitamin raw materials, specialty chemicals (including tire cord adhesive raw materials, agrochemical intermediates, and silicon compounds), and pharmaceutical raw materials and intermediates. The company operates across three product segments—amino acids, chemical products, and pharmaceuticals—serving diversified industrial end markets. Its integrated manufacturing capabilities and recent completion of new amino acid production facilities underscore its focus on expanding capacity in high-value specialty chemical segments.

Market Cap
¥7.91B
US$50.4M
EV
¥10.9B
US$69.3M
Stock¥366▼-1.35%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
7.2
x
LTM EV/EBIT
37.7
x
LTM PER
19.0
x
LTM PBR
0.6
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+4.9%pt
1001
Oct 24, 25 – Oct 23, 26StockTOPIX
1Mar 5, 26Technical rebound from previous day drop
MC → EV Bridge
7.91BUS$50.4MMarket Cap6.55BUS$41.8M+ Debt1.39BUS$8.89M− Cash2.20BUS$14.0M− Inv. Sec.10.9BUS$69.3MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
12.4US$78.8M'22/312.8US$81.9M'23/312.9US$82.5M'24/315.1US$96.5M'25/315.4US$98.5M'26/3
EBITDA 5Y (¥B)
1.31US$8.35M'22/31.83US$11.6M'23/32.10US$13.4M'24/32.25US$14.3M'25/31.62US$10.3M'26/3
Net Income 5Y (¥B)
0.25US$1.58M'22/30.56US$3.55M'23/30.78US$4.95M'24/30.90US$5.71M'25/30.31US$2.00M'26/3
Capital Structure
67%
33%
EquityD/E 0.49xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
3.36US$21.4M5.45US$34.8M'22/32.75US$17.6M5.50US$35.1M'23/32.60US$16.6M6.64US$42.3M'24/33.02US$19.3M8.42US$53.7M'25/33.23US$20.6M6.71US$42.8M'26/3
Shareholders
Top 10 hold 39.1%
1
NIPRO CORPORATION
15.25%
2
NAGASE & CO.,LTD.
5.08%
3
Hodogaya Chemical Co.,Ltd.
5.08%
4
Taiho Pharmaceutical Co., Ltd.
3.11%
5
Sumitomo Shoji Chemicals Co., Ltd.
2.48%
6
ZERIA PHARMACEUTICAL CO.,LTD.
2.23%
7
ASKA pharmaceutical Co., Ltd.
1.69%
8
Sanyo Fine Co., Ltd.
1.42%
9
Kimi Unso Co., Ltd.
1.41%
10
Yamaguchi Yakuhin Shokai Co., Ltd.
1.40%
Management
6 officers
Seiichiro MATSUMOTO
Representative Director, President and Executive Officer, in charge of Sales Division
Aug 1991 Joined the Company Oct 2011 General Manager, Pharmaceuticals Division Jan 2012 General Manager, Chemicals Division; concurrently General Manager, Pharmaceuticals Division Nov 2013 General Manager, Pharmaceuticals Division Jun 2015 Executive Officer; General Manager, Pharmaceuticals Division Jun 2017 Director, Executive Officer Jun 2019 Representative Director, President and Executive Officer (current)
1966-01-24
Masahiro KUSANO
Director, Managing Executive Officer, in charge of R&D and Production Divisions
Apr 1991 Joined the Company Aug 2012 Production Control Manager, Joban Plant Oct 2015 Manager, No. 1 Production Department, Joban Plant Apr 2019 Plant Manager, Joban Plant; concurrently Manager, No. 1 Production Department Jun 2020 Executive Officer; Plant Manager, Joban Plant; concurrently Manager, No. 1 Production Department Oct 2020 Executive Officer; Plant Manager, Joban Plant Jun 2021 Director, Executive Officer Jun 2023 Director, Managing Executive Officer (current)
1966-08-29
Taiyo ISHIKAWA
Director, Senior Executive Officer, in charge of Corporate Management Division
Apr 1995 Joined the Company Jun 2011 General Manager, General Affairs and Human Resources Department May 2014 Manager, Management Administration Office Jun 2016 Manager, Corporate Planning Office May 2018 Manager, Administration Department, Joban Plant Aug 2020 General Manager, General Affairs and Human Resources Department Jun 2021 Executive Officer; General Manager, General Affairs and Human Resources Department Jun 2025 Director, Senior Executive Officer (current)
1970-06-26
Naotake SUDO
Director (Full-time Audit and Supervisory Committee Member)
Apr 1981 Joined the Company Jan 1999 Laboratory Manager, Tokyo Research Laboratory Apr 2001 Joined Kanto Denka Kogyo Co., Ltd. Jun 2011 Head, Fukuoka Sales Office, Kanto Denka Kogyo Co., Ltd. Jul 2013 Head, Mizushima Development Laboratory, Kanto Denka Kogyo Co., Ltd. Jun 2015 General Manager, Development Sales Department, Kanto Denka Kogyo Co., Ltd. Jun 2017 Full-time Audit & Supervisory Board Member, affiliate of Kanto Denka Kogyo Co., Ltd. Jul 2019 Joined the Company as Advisor Jun 2020 Director (Audit and Supervisory Committee Member) of the Company (current)
1959-01-24
Keisuke YAMADA
Outside Director (Audit and Supervisory Committee Member)
Apr 1985 Joined Deloitte Haskins & Sells Certified Public Accountants' Joint Office (currently Tohmatsu LLC) Mar 1988 Registered as Certified Public Accountant Sep 1989 Registered as Certified Tax Accountant Jan 2010 Established Keisuke Yamada Certified Public Accountant and Tax Accountant Office (current) Joined Yamada Sanshoku Ltd. (current) Mar 2011 Outside Audit & Supervisory Board Member, Billing System Co., Ltd. (current) Jun 2014 Outside Director of the Company Jun 2016 Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1958-05-19
Norihito OHORI
Outside Director (Audit and Supervisory Committee Member)
Oct 2004 Registered as attorney (Daiichi Tokyo Bar Association) Oct 2004 Joined Momo-o, Matsuo & Namba Sep 2010 Joined Weil, Gotshal & Manges (U.S.) Sep 2011 Returned to Momo-o, Matsuo & Namba Jan 2014 Partner, Momo-o, Matsuo & Namba (current) Jun 2020 Outside Director (Audit and Supervisory Committee Member) of the Company (current)
1978-10-25
Large Shareholding Reports
No filings
Disclosures
No disclosures
Primary Source Filings
TDnet
2026-07-31
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-23
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-01-30
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-13
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-07-31
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-19
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-01-31
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-13
Semi-Annual Securities Report
Period: Apr 2024 – Sep 2024
TDnet
2024-07-31
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-24
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-13
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-13
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-10
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-26
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-13
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-11
Quarterly Securities Report
EDINET
2022-08-10
Quarterly Securities Report
EDINET
2022-06-22
Annual Securities Report
EDINET
2022-02-10
Quarterly Securities Report
EDINET
2021-11-12
Quarterly Securities Report
EDINET
2021-08-12
Quarterly Securities Report
EDINETAmended
2021-07-08
Amended Annual Securities Report
EDINET
2021-06-23
Annual Securities Report
EDINET
2021-02-12
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →